HCWB
HCW Biologics Inc
NASDAQ: HCWB · HEALTHCARE · BIOTECHNOLOGY
$0.47
+15.63% today
Updated 2026-04-30
Market cap
$2.53M
P/E ratio
—
P/S ratio
54.51x
EPS (TTM)
$-10.63
Dividend yield
—
52W range
$0 – $11
Volume
10.9M
HCW Biologics Inc (HCWB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-18,370.00%
ROE
-27,726.00%
ROA
-31.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-7.29M | — | — | — |
| 2020 | $4.10M | $-5.78M | 100.00% | -142.07% | -140.98% |
| 2021 | $4.10M | $-12.86M | -13.26% | -326.06% | -313.74% |
| 2022 | $6.72M | $-14.90M | 38.48% | -224.32% | -221.67% |
| 2023 | $2.84M | $-24.99M | 19.72% | -904.96% | -879.52% |
| 2024 | $2.57M | $-30.02M | 37.38% | -1,148.50% | -1,169.70% |
| 2025 | $54232.00 | $-7.96M | 20.00% | -20,757.65% | -14,677.14% |